Hikma at a glance
Discover what drives us
Latest news
Featured
Hikma delivers Group revenue and profit growth and announces share buyback and leadership changes
Press Release, Financial Results
- Working at Hikma’s Zagreb R&D hub: meet Nera Marjanovic Story, Life at Hikma 08 May 2026 Working at Hikma’s Zagreb R&D hub: meet Nera Marjanovic
- Why the world needs more companies like Hikma. By Said Darwazah, Chief Executive Officer Insight, Corporate 07 May 2026 Why the world needs more companies like Hikma. By Said Darwazah, Chief Executive Officer
- Hikma Pharmaceuticals and Marius Pharmaceuticals announce licensing agreement for KYZATREX® (testosterone undecanoate) CIII capsules in Canada Press Release, Product 05 May 2026 Hikma Pharmaceuticals and Marius Pharmaceuticals announce licensing agreement for KYZATREX® (testosterone undecanoate) CIII capsules in Canada
- Hikma announces settlement agreement for VYNDAMAX® (tafamidis) Press Release, Corporate 28 April 2026 Hikma announces settlement agreement for VYNDAMAX® (tafamidis)